Cancer Research SABCS EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 59, 3433-3441, July 1, 1999]
© 1999 American Association for Cancer Research
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parish, C. R.
Right arrow Articles by Cowden, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parish, C. R.
Right arrow Articles by Cowden, W. B.
[Cancer Research 59, 3433-3441, July 15, 1999]
© 1999 American Association for Cancer Research

Experimental Therapeutics

Identification of Sulfated Oligosaccharide-based Inhibitors of Tumor Growth and Metastasis Using Novel in Vitro Assays for Angiogenesis and Heparanase Activity1

Christopher R. Parish2, Craig Freeman, Kathryn J. Brown, Douglas J. Francis and William B. Cowden

Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra 2601, Australia

Inhibitors of tumor angiogenesis and metastasis are rapidly emerging as important new drug candidates for cancer therapy. To facilitate the identification of such drugs, we recently developed novel and rapid in vitro assays for human angiogenesis and for the extracellular matrix-degrading enzyme heparanase, which has been implicated in tumor metastasis. In this study, sulfated oligosaccharides, which are structural mimics of heparan sulfate, were investigated as drug candidates because these compounds may interfere with heparan sulfate recognition by many angiogenic growth factors and may inhibit cleavage of heparan sulfate by heparanase. In the preliminary screening studies, it was found that inhibitory activity in both assay systems was critically dependent on chain length and degree of sulfation, highly sulfated linear oligosaccharides of five or more monosaccharides in length being the most active. However, two sulfated oligosaccharides stood out as potential antitumor drugs, phosphomannopentaose sulfate (PI-88) and maltohexaose sulfate, both of these compounds having the important property of simultaneously being potent inhibitors of in vitro angiogenesis and heparanase activity. Due to the ease of manufacture of the starting material, phosphomannopentaose, PI-88 was studied in more detail. PI-88 was shown to inhibit the primary tumor growth of the highly invasive rat mammary adenocarcinoma 13762 MAT by ~50%, inhibit metastasis to the draining popliteal lymph node by ~40%, and reduce the vascularity of tumors by ~30%, all of these effects being highly significant. Acute hematogenous metastasis assays also demonstrated that PI-88 was a potent (>90%) inhibitor of blood-borne metastasis. Thus, by the use of novel in vitro screening procedures, we have identified a promising antitumor agent.




This article has been cited by other articles:


Home page
 GlycobiologyHome page
V. Friand, O. Haddad, D. Papy-Garcia, H. Hlawaty, R. Vassy, Y. Hamma-Kourbali, G.-Y. Perret, J. Courty, F. Baleux, O. Oudar, et al.
Glycosaminoglycan mimetics inhibit SDF-1/CXCL12-mediated migration and invasion of human hepatoma cells
Glycobiology, December 1, 2009; 19(12): 1511 - 1524.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
E. Karathanasis, S. Suryanarayanan, S. R. Balusu, K. McNeeley, I. Sechopoulos, A. Karellas, A. V. Annapragada, and R. V. Bellamkonda
Imaging Nanoprobe for Prediction of Outcome of Nanoparticle Chemotherapy by Using Mammography
Radiology, February 1, 2009; 250(2): 398 - 406.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Mikami, M. Oya, M. Shimoda, R. Mizuno, M. Ishida, T. Kosaka, M. Mukai, M. Nakajima, and Y. Okada
Expression of Heparanase in Renal Cell Carcinomas: Implications for Tumor Invasion and Prognosis
Clin. Cancer Res., October 1, 2008; 14(19): 6055 - 6061.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T.-c. Fan, S.-l. Fang, C.-s. Hwang, C.-y. Hsu, X.-a. Lu, S.-c. Hung, S.-C. Lin, and M. D.-T. Chang
Characterization of Molecular Interactions between Eosinophil Cationic Protein and Heparin
J. Biol. Chem., September 12, 2008; 283(37): 25468 - 25474.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
N. Hostettler, A. Naggi, G. Torri, R. Ishai-Michaeli, B. Casu, I. Vlodavsky, and L. Borsig
P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins
FASEB J, November 1, 2007; 21(13): 3562 - 3572.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
S. S D'Souza, T. Daikoku, M. C Farach-Carson, and D. D Carson
Heparanase Expression and Function During Early Pregnancy in Mice
Biol Reprod, September 1, 2007; 77(3): 433 - 441.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Simizu, T. Suzuki, M. Muroi, N. S. Lai, S. Takagi, N. Dohmae, and H. Osada
Involvement of Disulfide Bond Formation in the Activation of Heparanase
Cancer Res., August 15, 2007; 67(16): 7841 - 7849.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Mahtouk, D. Hose, P. Raynaud, M. Hundemer, M. Jourdan, E. Jourdan, V. Pantesco, M. Baudard, J. De Vos, M. Larroque, et al.
Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma
Blood, June 1, 2007; 109(11): 4914 - 4923.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Xu, G. Rao, R. M. Quiros, A. W. Kim, H.-Q. Miao, G. J. Brunn, J. L. Platt, P. Gattuso, and R. A. Prinz
In Vivo and in Vitro Degradation of Heparan Sulfate (HS) Proteoglycans by HPR1 in Pancreatic Adenocarcinomas: LOSS OF CELL SURFACE HS SUPPRESSES FIBROBLAST GROWTH FACTOR 2-MEDIATED CELL SIGNALING AND PROLIFERATION
J. Biol. Chem., January 26, 2007; 282(4): 2363 - 2373.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Gotte and G. W. Yip
Heparanase, Hyaluronan, and CD44 in Cancers: A Breast Carcinoma Perspective
Cancer Res., November 1, 2006; 66(21): 10233 - 10237.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Basche, D. L. Gustafson, S. N. Holden, C. L. O'Bryant, L. Gore, S. Witta, M. K. Schultz, M. Morrow, A. Levin, B. R. Creese, et al.
A Phase I Biological and Pharmacologic Study of the Heparanase Inhibitor PI-88 in Patients with Advanced Solid Tumors.
Clin. Cancer Res., September 15, 2006; 12(18): 5471 - 5480.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Zhao, H. Liu, Y. Chen, X. Xin, J. Li, Y. Hou, Z. Zhang, X. Zhang, C. Xie, M. Geng, et al.
Oligomannurarate Sulfate, a Novel Heparanase Inhibitor Simultaneously Targeting Basic Fibroblast Growth Factor, Combats Tumor Angiogenesis and Metastasis.
Cancer Res., September 1, 2006; 66(17): 8779 - 8787.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
Y. Adams, C. Freeman, R. Schwartz-Albiez, V. Ferro, C. R. Parish, and K. T. Andrews
Inhibition of Plasmodium falciparum Growth In Vitro and Adhesion to Chondroitin-4-Sulfate by the Heparan Sulfate Mimetic PI-88 and Other Sulfated Oligosaccharides.
Antimicrob. Agents Chemother., August 1, 2006; 50(8): 2850 - 2852.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Hasan, S. D. Shnyder, A. R. Clamp, A. T. McGown, R. Bicknell, M. Presta, M. Bibby, J. Double, S. Craig, D. Leeming, et al.
Heparin Octasaccharides Inhibit Angiogenesis In vivo
Clin. Cancer Res., November 15, 2005; 11(22): 8172 - 8179.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. M. de Mestre, S. Rao, J. R. Hornby, T. Soe-Htwe, L. M. Khachigian, and M. D. Hulett
Early Growth Response Gene 1 (EGR1) Regulates Heparanase Gene Transcription in Tumor Cells
J. Biol. Chem., October 21, 2005; 280(42): 35136 - 35147.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Kelly, L. J. Suva, Y. Huang, V. MacLeod, H.-Q. Miao, R. C. Walker, and R. D. Sanderson
Expression of Heparanase by Primary Breast Tumors Promotes Bone Resorption in the Absence of Detectable Bone Metastases
Cancer Res., July 1, 2005; 65(13): 5778 - 5784.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. B. Maxhimer, M. Somenek, G. Rao, C. E. Pesce, D. Baldwin Jr., P. Gattuso, M. M. Schwartz, E. J. Lewis, R. A. Prinz, and X. Xu
Heparanase-1 Gene Expression and Regulation by High Glucose in Renal Epithelial Cells: A Potential Role in the Pathogenesis of Proteinuria in Diabetic Patients
Diabetes, July 1, 2005; 54(7): 2172 - 2178.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. Levy-Adam, G. Abboud-Jarrous, M. Guerrini, D. Beccati, I. Vlodavsky, and N. Ilan
Identification and Characterization of Heparin/Heparan Sulfate Binding Domains of the Endoglycosidase Heparanase
J. Biol. Chem., May 27, 2005; 280(21): 20457 - 20466.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Naggi, B. Casu, M. Perez, G. Torri, G. Cassinelli, S. Penco, C. Pisano, G. Giannini, R. Ishai-Michaeli, and I. Vlodavsky
Modulation of the Heparanase-inhibiting Activity of Heparin through Selective Desulfation, Graded N-Acetylation, and Glycol Splitting
J. Biol. Chem., April 1, 2005; 280(13): 12103 - 12113.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Freeman, L. Liu, M. G. Banwell, K. J. Brown, A. Bezos, V. Ferro, and C. R. Parish
Use of Sulfated Linked Cyclitols as Heparan Sulfate Mimetics to Probe the Heparin/Heparan Sulfate Binding Specificity of Proteins
J. Biol. Chem., March 11, 2005; 280(10): 8842 - 8849.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
E. Zcharia, R. Zilka, A. Yaar, O. Yacoby-Zeevi, A. Zetser, S. Metzger, R. Sarid, A. Naggi, B. Casu, N. Ilan, et al.
Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models
FASEB J, February 1, 2005; 19(2): 211 - 221.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
V. Levidiotis, C. Freeman, M. Punler, P. Martinello, B. Creese, V. Ferro, J. van der Vlag, J. H.M. Berden, C. R. Parish, and D. A. Power
A Synthetic Heparanase Inhibitor Reduces Proteinuria in Passive Heymann Nephritis
J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2882 - 2892.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
K. Ishida, G. Hirai, K. Murakami, T. Teruya, S. Simizu, M. Sodeoka, and H. Osada
Structure-based design of a selective heparanase inhibitor as an antimetastatic agent
Mol. Cancer Ther., September 1, 2004; 3(9): 1069 - 1077.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
E. Edovitsky, M. Elkin, E. Zcharia, T. Peretz, and I. Vlodavsky
Heparanase Gene Silencing, Tumor Invasiveness, Angiogenesis, and Metastasis
J Natl Cancer Inst, August 18, 2004; 96(16): 1219 - 1230.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Alifano, G. Benedetti, and R. Trisolini
Can Low-Molecular-Weight Heparin Improve the Outcome of Patients With Operable Non-Small Cell Lung Cancer?: An Urgent Call for Research
Chest, August 1, 2004; 126(2): 601 - 607.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
X. He, P. E. C. Brenchley, G. C. Jayson, L. Hampson, J. Davies, and I. N. Hampson
Hypoxia Increases Heparanase-Dependent Tumor Cell Invasion, Which Can Be Inhibited by Antiheparanase Antibodies
Cancer Res., June 1, 2004; 64(11): 3928 - 3933.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
A. Zetser, F. Levy-Adam, V. Kaplan, S. Gingis-Velitski, Y. Bashenko, S. Schubert, M. Y. Flugelman, I. Vlodavsky, and N. Ilan
Processing and activation of latent heparanase occurs in lysosomes
J. Cell Sci., May 1, 2004; 117(11): 2249 - 2258.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Kelly, H.-Q. Miao, Y. Yang, E. Navarro, P. Kussie, Y. Huang, V. MacLeod, J. Casciano, L. Joseph, F. Zhan, et al.
High Heparanase Activity in Multiple Myeloma Is Associated with Elevated Microvessel Density
Cancer Res., December 15, 2003; 63(24): 8749 - 8756.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Elkin, I. Cohen, E. Zcharia, A. Orgel, Z. Guatta-Rangini, T. Peretz, I. Vlodavsky, and H. K. Kleinman
Regulation of Heparanase Gene Expression by Estrogen in Breast Cancer
Cancer Res., December 15, 2003; 63(24): 8821 - 8826.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. M. de Mestre, L. M. Khachigian, F. S. Santiago, M. A. Staykova, and M. D. Hulett
Regulation of Inducible Heparanase Gene Transcription in Activated T Cells by Early Growth Response 1
J. Biol. Chem., December 12, 2003; 278(50): 50377 - 50385.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
O. GOLDSHMIDT, E. ZCHARIA, M. COHEN, H. AINGORN, I. COHEN, L. NADAV, B.-Z. KATZ, B. GEIGER, and I. VLODAVSKY
Heparanase mediates cell adhesion independent of its enzymatic activity
FASEB J, June 1, 2003; 17(9): 1015 - 1025.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
D. J. Francis, C. R. Parish, M. McGarry, F. S. Santiago, H. C. Lowe, K. J. Brown, J. A. Bingley, I. P. Hayward, W. B. Cowden, J. H. Campbell, et al.
Blockade of Vascular Smooth Muscle Cell Proliferation and Intimal Thickening After Balloon Injury by the Sulfated Oligosaccharide PI-88: Phosphomannopentaose Sulfate Directly Binds FGF-2, Blocks Cellular Signaling, and Inhibits Proliferation
Circ. Res., May 2, 2003; 92 (8): e70 - e77.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Bioactive and Compatible PolymersHome page
H. Baumann
Biological Effects of Heparan Sulfates and Regioselectively Modified Heparin-Heparan Mimetics
Journal of Bioactive and Compatible Polymers, January 1, 2003; 18(1): 59 - 81.
[Abstract] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Mukhopadhyay, J.-i. Sasaki, R. Ramesh, and J. A. Roth
Mebendazole Elicits a Potent Antitumor Effect on Human Cancer Cell Lines Both in Vitro and in Vivo
Clin. Cancer Res., September 1, 2002; 8(9): 2963 - 2969.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
O. Goldshmidt, E. Zcharia, R. Abramovitch, S. Metzger, H. Aingorn, Y. Friedmann, V. Schirrmacher, E. Mitrani, and I. Vlodavsky
Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis
PNAS, July 23, 2002; 99(15): 10031 - 10036.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
L. Nadav, A. Eldor, O. Yacoby-Zeevi, E. Zamir, I. Pecker, N. Ilan, B. Geiger, I. Vlodavsky, and B.-Z. Katz
Activation, processing and trafficking of extracellular heparanase by primary human fibroblasts
J. Cell Sci., May 15, 2002; 115(10): 2179 - 2187.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
M. A. Rosenthal, D. Rischin, G. McArthur, K. Ribbons, B. Chong, J. Fareed, G. Toner, M. D. Green, and R. L. Basser
Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia
Ann. Onc., May 1, 2002; 13(5): 770 - 776.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. Uno, T. Fujiwara, Y. Takata, S. Ohtani, K. Katsuda, M. Takaoka, T. Ohkawa, Y. Naomoto, M. Nakajima, and N. Tanaka
Antisense-mediated Suppression of Human Heparanase Gene Expression Inhibits Pleural Dissemination of Human Cancer Cells
Cancer Res., November 1, 2001; 61(21): 7855 - 7860.
[Abstract] [Full Text] [PDF]

Home page
 CLIN APPL THROMB HEMOSTHome page
M. Demir, O. Iqbal, D. A. Hoppensteadt, P. Piccolo, S. Ahmad, C. L. Schultz, R. J. Linhardt, and J. Fareed
Anticoagulant and Antiprotease Profiles of a Novel Natural Heparinomimetic Mannopentaose Phosphate Sulfate (PI-88)
Clinical and Applied Thrombosis/Hemostasis, April 1, 2001; 7(2): 131 - 140.
[Abstract] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Borsig, R. Wong, J. Feramisco, D. R. Nadeau, N. M. Varki, and A. Varki
Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis
PNAS, March 13, 2001; 98(6): 3352 - 3357.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
S. M. Smorenburg and C. J. F. Van Noorden
The Complex Effects of Heparins on Cancer Progression and Metastasis in Experimental Studies
Pharmacol. Rev., March 1, 2001; 53(1): 93 - 106.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
R. S. Kerbel
Tumor angiogenesis: past, present and the near future
Carcinogenesis, March 1, 2000; 21(3): 505 - 515.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
O. Goldshmidt, E. Zcharia, H. Aingorn, Z. Guatta-Rangini, R. Atzmon, I. Michal, I. Pecker, E. Mitrani, and I. Vlodavsky
Expression Pattern and Secretion of Human and Chicken Heparanase Are Determined by Their Signal Peptide Sequence
J. Biol. Chem., July 27, 2001; 276(31): 29178 - 29187.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.